- Home
- CPOP vs NXL Comparison
CPOP vs NXL Comparison
Compare CPOP & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPOP | NXL |
|---|---|---|
| Founded | 2007 | 2010 |
| Country | China | United States |
| Employees | N/A | 8 |
| Industry | Services-Misc. Amusement & Recreation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9M | 10.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | CPOP | NXL |
|---|---|---|
| Price | $0.36 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 13.2M | 269.0K |
| Earning Date | 11-17-2025 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $15.52 |
| Revenue Next Year | N/A | $100.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $0.31 |
| 52 Week High | $2.60 | $2.00 |
Technical Indicators
Market Signals| Indicator | CPOP | NXL |
|---|---|---|
| Relative Strength Index (RSI) | 50.31 | 41.79 |
| Support Level | $0.05 | $0.35 |
| Resistance Level | $0.36 | $0.49 |
| Average True Range (ATR) | 0.07 | 0.05 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 51.03 | 20.72 |
Price Performance
Historical ComparisonAbout CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the US and China, with China generating the maximum sales.